Ionis Pharmaceuticals Inc
Company Profile
Business description
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
Contact
2855 Gazelle Court
Carlsbad CA 92010
USAT: +1 760 931-9200
E: WWalke@ionisph.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
927
Ionis Pharmaceuticals Inc News & Analysis
stocks
Global healthcare stocks for your watchlist
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,243.30 | 19.10 | -0.23% |
| CAC 40 | 7,589.79 | 42.92 | -0.56% |
| DAX 40 | 18,506.71 | 84.18 | -0.45% |
| Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
| FTSE 100 | 8,160.52 | 22.44 | -0.27% |
| HKSE | 17,759.38 | 256.56 | -1.42% |
| NASDAQ | 18,472.57 | 74.12 | 0.40% |
| Nikkei 225 | 41,275.08 | 84.40 | 0.20% |
| NZX 50 Index | 12,184.49 | 61.35 | 0.51% |
| S&P 500 | 5,631.22 | 15.87 | 0.28% |
| S&P/ASX 200 | 7,999.30 | 18.30 | -0.23% |
| SSE Composite Index | 2,976.30 | 2.29 | 0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Droneshield Ltd DRO | 2.02 | 0.58 | -22.31% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -2.94% |
| Red 5 Ltd RED | 0.42 | 0.00 | 0.00% |
| Mirvac Group MGR | 2.12 | 0.04 | 1.92% |
| Opthea Ltd OPT | 0.38 | 0.01 | -1.32% |
| Imugene Ltd IMU | 0.06 | 0.00 | -3.51% |
| Telstra Group Ltd TLS | 3.83 | 0.01 | -0.26% |
| Bellevue Gold Ltd BGL | 1.87 | 0.07 | -3.37% |
| Latin Resources Ltd LRS | 0.16 | 0.01 | -5.88% |
| Zip Co Ltd ZIP | 1.61 | 0.03 | 1.90% |